BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37732096)

  • 1. The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study.
    Nowiński A; Wesołowski S; Korzeniewska-Koseła M
    Front Public Health; 2023; 11():1253615. PubMed ID: 37732096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcoholism and other socio-demographic risk factors for adverse TB-drug reactions and unsuccessful tuberculosis treatment - data from ten years' observation at the Regional Centre of Pulmonology, Bydgoszcz, Poland.
    Przybylski G; Dąbrowska A; Trzcińska H
    Med Sci Monit; 2014 Mar; 20():444-53. PubMed ID: 24643127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis in Poland in 2017.
    Korzeniewska- Koseła M
    Przegl Epidemiol; 2019; 73(2):211-226. PubMed ID: 31385679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis in Poland in 2018.
    Korzeniewska-Koseła M
    Przegl Epidemiol; 2020; 74(2):239-257. PubMed ID: 33112107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis in Poland in 2016.
    Korzeniewska-Koseła M
    Przegl Epidemiol; 2018; 72(2):189-205. PubMed ID: 30111079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of mortality and treatment success of multi-drug resistant and Rifampicin resistant tuberculosis in Zimbabwe: a retrospective cohort analysis of patients initiated on treatment during 2010 to 2015.
    Matambo R; Nyandoro G; Sandy C; Nkomo T; Mutero-Munyati S; Mharakurwa S; Chikaka E; Ngwenya M; Ndongwe G; Pepukai VM
    Pan Afr Med J; 2021; 39():128. PubMed ID: 34527144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis in homeless persons in Poland.
    Korzeniewska-Koseła M; Kuś J; Lewandowska K; Siemion-Szcześniak I
    Przegl Epidemiol; 2015; 69(3):445-51, 575-80. PubMed ID: 26519838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis in Poland in 2014.
    Korzeniewska-Koseła M
    Przegl Epidemiol; 2016; 70(2):261-272. PubMed ID: 27824436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis in Poland in 2012.
    Korzeniewska-Koseła M
    Przegl Epidemiol; 2014; 68(2):295-300, 389-93. PubMed ID: 25135518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug addiction and alcoholism as predictors for tuberculosis treatment default in Brazil: a prospective cohort study.
    Silva MR; Pereira JC; Costa RR; Dias JA; Guimarães MDC; Leite ICG
    Epidemiol Infect; 2017 Dec; 145(16):3516-3524. PubMed ID: 29173226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are they there yet? Linkage of patients with tuberculosis to services for tobacco cessation and alcohol abuse - a mixed methods study from Karnataka, India.
    Navya N; Jeyashree K; Madhukeshwar AK; Anand T; Nirgude AS; Nayarmoole BM; Isaakidis P
    BMC Health Serv Res; 2019 Feb; 19(1):90. PubMed ID: 30709351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.
    Nglazi MD; Bekker LG; Wood R; Kaplan R
    BMC Infect Dis; 2015 Nov; 15():536. PubMed ID: 26584607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: A registry-based cohort study.
    Tok PSK; Liew SM; Wong LP; Razali A; Loganathan T; Chinna K; Ismail N; Kadir NA
    PLoS One; 2020; 15(4):e0231986. PubMed ID: 32320443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis in Poland in 2020.
    Korzeniewska-Koseła M; Wesołowski S
    Przegl Epidemiol; 2022; 76(4):528-546. PubMed ID: 37017237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
    Park S; Jo KW; Lee SD; Kim WS; Shim TS
    Respir Med; 2017 Oct; 131():43-48. PubMed ID: 28947041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality and survival probability distribution among patients on tuberculosis treatment in Vihiga County, Kenya.
    Wekunda PW; Aduda DSO; Guyah B; Odongo J
    Afr Health Sci; 2023 Mar; 23(1):218-230. PubMed ID: 37545936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of tuberculosis and mycobacteriosis among HIV-infected patients--clinical and epidemiological analysis of patients from north-eastern Poland.
    Łucejko M; Grzeszczuk A; Rogalska M; Flisiak R
    Pneumonol Alergol Pol; 2013; 81(6):502-10. PubMed ID: 24142779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis in Poland in 2013.
    Korzeniewska-Koseła M
    Przegl Epidemiol; 2015; 69(2):277-82, 389-93. PubMed ID: 26233087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis.
    Azeez A; Ndege J; Mutambayi R
    Int J Mycobacteriol; 2018; 7(4):347-354. PubMed ID: 30531033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes and risk factors of extra-pulmonary tuberculosis in patients with co-morbidities.
    Khan AH; Sulaiman SAS; Laghari M; Hassali MA; Muttalif AR; Bhatti Z; Ming LC; Talpur BA
    BMC Infect Dis; 2019 Aug; 19(1):691. PubMed ID: 31382889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.